objective To determine the prevalence and factors associated with optimal antiretroviral therapy (ART) adherence and virological failure (VLF) among HIV-infected adults enrolled in the national ART programme at the teaching hospital of Fann, Dakar, Senegal.
Introduction
Suboptimal ART adherence can lead to increased risk of virological failure [1] [2] [3] [4] [5] , disease progression [6] , drug resistance [7] , high plasma viral load, subsequent risk of sexual transmission [8, 9] and death [10, 11] . Although earlier reports suggested that ART adherence in resource-limited settings is often equal to or higher than in resource-rich settings [12] [13] [14] , several studies have reported rates ranging from 68% to 90% [15] [16] [17] [18] and that these rates may decrease over time [19] . *J.B. Nachega and M. Seydi co-supervised the overall work and met the criteria for joint senior authorship status.
Globally, the most reported ART adherence barriers include forgetfulness, non-disclosure of HIV serostatus, stigma, ART-related side effects and competing patient responsibilities. These barriers can be categorised as individual, interpersonal, community or structural factors [20] . Cost issues and structural barriers, such as lack of transportation and pharmacy stock-outs, are particularly prevalent in sub-Saharan Africa [17, 21, 22] .
Early programmatic data of ART adherence conducted in the late 1900s/early 2000s from Senegal reported levels of adherence between 87% and 91% [23, 24] , with treatment cost and type of ART combinations named as major barriers to adherence [24] . However, since 2003, access to ART has improved along with the availability of better-tolerated, simplified regimens, such as generic fixed-dose single-tablet regimens that are currently in wide clinical use [25] . Little is known about level and factors associated with ART adherence and virological outcomes to these contemporary ART regimens in Senegal.
We aimed to investigate (1) the level of ART adherence in HIV-infected adults on contemporary ART regimens; (2) the associated factors for suboptimal adherence as well as virological outcomes in Dakar, Senegal; and (3) the diagnostic accuracy of CASE Index Score as ART adherence monitoring tool in this setting.
Patients and methods

Study design, setting and population
We conducted a cross-sectional study from 1 September 2013 to 30 January 2014, at the teaching hospital of Fann, Senegal, Dakar. Using a simple random sampling technique, HIV-infected adults (≥18 years old) who had been on ART for a period of at least 6 months were eligible to participate after giving written informed consent.
Explanatory and outcome variables
A standardised questionnaire was administered to capture baseline explanatory or independent variables (socio-demographics, clinical and biological information, and ART data). The primary outcome was ART adherence as measured by the Center for Adherence Support Evaluation (CASE) Index Score. This is a validated ART adherence monitoring tool using a composite (sum) of three simple, self-reported ART adherence questions: difficulty taking ART medication on time, average number of days per week with at least one missed dose and last time the patient missed at least one dose (see e-Appendix), with a score range from 3 to 16 and higher scores indicating better adherence [26, 27] . Patients with a CASE Index Score >10 were defined as having optimal adherence. Primary outcome was defined as HIV RNA ≥1000 copies/ml, a threshold recommended by WHO for defining breakthrough viremia in resource-limited settings [28] . Sensitivity analyses were performed by varying VLF thresholds (>50, >400 and >1000 c/ml).
Statistical analysis
We performed bivariate analyses to compare proportions and means for selected variables between adherence and non-adherence groups using the chi-square test and ttest, respectively. Diagnostic accuracy of the CASE Index Score for detecting VLF is reported in accordance with the Standards for Reporting of Diagnostic Accuracy (STARD) recommendations and includes sensitivity (Se), specificity (Sp), positive and negative predictive values (PPV and NPV), and related 95% confidence intervals (CI) [29] . Multivariate exact logistic regression model was built to examine independent association between baseline characteristics and adherence to ART as well as to virological failure (VL ≥ 1000 copies/ml). The cut-off for including a variable in the multivariate logistic regression model was P < 0.2 from the bivariate analysis, and only non-collinear variables were included in the final model, following a manual forward stepwise method. Model fit was assessed by the Hosmer-Lemeshow goodness-of-fit test. A linear regression model was built, and the Pearson's correlation coefficient was computed, to examine the linear association between logtransformed viral load (log HIV RNA) and CASE Index Score. Stata Software IC version 13.1 was used for all statistical analyses. Research ethics committee approval was obtained from the National Health Research Ethics Committee of Senegal (Ethics Reference #148 MSAS/ DPRS/DR).
Results
Baseline socio-demographic and clinical characteristics
Of 98 HIV-infected patients started on ART, 67% were female. The median (IQR) age was 42 (52-38) years. A total of 57 of 98 (58%) were on ART more than 3 years and the majority (88%) were on efavirenz-or nevirapine-based ART regimen. Twenty-seven (28%) patients were classified as WHO clinical grade IV. Sixty (61.2%) had a CD4+ T-cell count less or equal to 350 cells/m 3 (Table 1) .
ART adherence, virological outcomes in bivariate comparisons and case diagnostic accuracy Seventy-nine patients of ninety-eight (87.7%) had optimal ART adherence based on the CASE Index Score. Patients with optimal adherence were significantly more likely to be older ( ART, antiretroviral therapy; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitor. 
Factors associated with ART Adherence and virological outcomes in logistic regression model
Factors independently associated with VLF were CASE Index Score <10 ([aOR] = 13.0, 95% CI: 1.1-147.9; P = 0.04) and being a boosted PI-based ART regimen ([aOR] = 27.0, 95% CI: 2.4-309.4; P = 0.008) ( Table 3) . In linear regression analysis, there was a statistically significant negative linear correlation between CASE Index Score and plasma HIV viral load (r = À0.15, P = 0.03) (Figure 1) . In other words, for every unit increase in ART adherence, the plasma HIV viral load decreases by 0.15 and vice versa. Furthermore, r 2 = 0.02 and indicates the variance in CASE Index Score 'explained by' HIV viral load. Although 2.2% is very low, it is significantly different from 0.
Discussion
Our study found that a high proportion (87.8%) of patients had optimal ART adherence and this was associated with a low prevalence (5%) of breakthrough viremia. Furthermore, the majority (about 60%) of these optimally adherent patients were on ART for more than 3 years. Such a high proportion of patients with optimal ART adherence is in line with earlier reports from other countries in sub-Saharan Africa [15, 16, 18, 23, 24] .
The most reported cause of suboptimal ART adherence was forgetfulness, followed by social barriers and ARTrelated factors. Structural barriers (e.g. distance to the health facility) were not significantly associated with suboptimal ART adherence, as other investigators have also found [22] . The same was true for HIV status disclosure [30] [31] [32] [33] [34] . The latter may reflect acceptance of patients with AIDS by their households. Reported benefits of HIV status disclosure are increased social support and medication adherence and decreased depression risk. However, possible hazards associated with disclosure include intimate partner violence, stigma, discrimination and abandonment.
Optimal ART adherence (as evaluated by the CASE Index Score) and being on a PI-based ART regimen were independently associated with VLF. Antiretroviral therapy adherence as a predictor of virological outcomes is well established [2] [3] [4] [5] , but to our knowledge, this is the first study showing evidence of a statistical significance between ART adherence as measured by CASE Index Score and virological suppression in Africa and therefore validating its usefulness in this setting. There is no gold standard to measure ART adherence [35] . Commonly used methods include pill counts, electronic monitoring, therapeutic drug levels, pharmacy records and self-report, each of which has advantages and disadvantages depending on the setting. Self-report and pharmacy refill are the most common approaches used in Africa due to the low cost and simplicity. Both methods have limited sensitivity (e.g. social desirability bias for self-report) but a fair specificity [35] . The poor virological outcome associated with PI-based ART regimens is likely to reflect the fact that patients were VLF cases on NNRTI and were recently switched from NNRTI-to PI-based ART. Clumeck et al., reporting trial data from Lubumbashi in Democratic Republic of the Congo, showed that a first-line NNRTI-based ART regimen, when compared to a boosted PI-based regimen, provides similar outcome but is associated with a significantly higher risk of virological failure and resistance mutations in both classes that jeopardise future options for second-line therapy [36] . Indeed, NNRTIbased regimens have low barriers for resistance in the context of suboptimal ART adherence; PI-based regimens are more forgiving with relatively low adherence [37] which protects against the emergence of resistance in long-term failing patients [38] . However, these resistance considerations need to be balanced against other factors such as cost, availability of co-formulation as fixed-dose combinations, short-and long-term toxicity, and drugdrug interaction secondary to co-administration of ART and tuberculosis medication. NNRTI-based ART is still a WHO-recommended first-line regimen in resource-limited settings [28] , in contrast to guidelines in developed countries, which are moving towards first-line PI-based ART [28] . Cost-effectiveness data will help guide future policy decisions in this area.
Our study has several important clinical implications. First, long-term optimal ART adherence and low prevalence of VLF are achievable as ART programmes expand in sub-Saharan Africa. Second, we documented the best trade-off in sensitivity, specificity, positive and negative predictive values by use of CASE Index Score tool with a cut-off viral load >50 copies/ml (Table 2) . These data support the use of CASE Index Score as adherence monitoring tool to identify patients who required targeted evidence-based adherence interventions (e.g. counselling, social support, or mobile phone text messages reminders) [39] [40] [41] , before the emergence of HIV drug resistance which leads to VLF, with the ultimate goal of preventing medication switch towards costly second-or third-line ART regimens.
Strengths of our study include the use of a simple, practical, ART adherence monitoring tool which shows a significant negative correlation between Case Index Score and virological suppression and the documentation of ART adherence evaluated by CASE Index Score and type of ART as independent factor of VLF. While informative, our study also has some limitations. First, there exist the possibilities of selection bias due to limited sample size as well as reverse causation due to the cross-sectional study design. Also, the small sample size may have caused us to miss some important significance of interest and led to wide confidence intervals (imprecision) around selected estimates. Finally, given the urban nature of our study population and the tertiary health facility from which patients were recruited, the results of our study may not be generalisable to all centres (e.g. rural) in Senegal; larger multicentric prospective studies in urban and rural areas are more likely to be representative of ART adherence at national level in Senegal.
In summary, we found that a high proportion of HIVinfected adults had documented long-term optimal ART adherence and low prevalence of VLF, standards which are clearly achievable in Dakar, Senegal. Also, our data suggest that the CASE Index Score is useful to monitor ART adherence in this setting.
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